Clinical Trial Update: Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravenous oxytocin to reduce postoperative pain after minimally invasive hysterectomy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Oxytocin (Pitocin) (oxytocin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Postoperative Pain | Phase 2 | Status: RECRUITING